XNYS
DOC
Market cap13bUSD
Oct 30, Last price
19.03USD
1D
0.48%
1Q
-12.83%
Jan 2017
-35.97%
Name
Healthpeak Properties Inc
Chart & performance
P/E
183.91
P/S
4.65
EPS
0.10
Vol. 1Y
28.49%
Shs. 5Y
5.56%
Rev. 5Y
11.40%
Div Yld LY
6.41%
Div Yld TTM
6.41%
Revenues
2.82b
+4.52%
Net income
71m
-70.66%
CFO
1.25b
+16.95%
Dividend
Oct 19, 20260.10167 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Healthpeak Properties, Inc., an S&P 500 constituent, operates as a fully integrated real estate investment trust (REIT). The company specializes in the acquisition and development of premium properties across three private-pay healthcare segments: Life Science, Medical Office, and Senior Housing. This focus is meticulously crafted to deliver stability amidst the cyclical nature of the industry. Healthpeak leverages its profound expertise in the healthcare property market, coupled with an ambitious outlook for sustained, long-term expansion.
Related entities
Subsidiaries (5)
Healthpeak OP, LLC
Dr California III Holdings, LLC
Dr California IV Holdings, LLC
Janus Living OP, LLC
Janus Living, Inc.
Key people
President, Chief Executive Officer, Director · since 2022
Vice Chairman of the Board · since 2024
Kelvin Moses
Chief Financial Officer · since 2025
Chief Human Resources Officer, Executive Vice President · since 2020
Executive Vice President, Chief Accounting Officer · since 2019
Tracy Porter
Executive Vice President, General Counsel · since 2025
Adam Mabry
Chief Investment Officer · since 2022
Ankit Patadia
Executive Vice President and Treasurer - Corporate Finance · since 2023
Scott Bohn
Chief Development Officer and Head of Lab · since 2024
Independent Director · since 2023
Independent Director · since 2023
Independent Director · since 2018
Independent Director · since 2024
Independent Director · since 2019
Ava Lias-booker
Independent Director · since 2024
Non-Executive Independent Chairman of the Board · since 2023
Tommy Thompson
Independent Director · since 2024
Independent Director · since 2024
Legal address
C/O The Corporation Trust Incorporated
2405 York Road
Suite 201
Lutherville Timonium, MD 21093
US
2405 York Road
Suite 201
Lutherville Timonium, MD 21093
US
Headquarters
4600 South Syracuse Street
Suite 500
Denver, CO 80237
US
Suite 500
Denver, CO 80237
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||